Link between menstrual changes after COVID-19 vaccination is plausible and should be investigatedBMJ
Some women say their periods change after getting a covid-19 vaccination.
Some women say their periods change after getting a covid-19 vaccination.
1) Cigarette smokers may have heightened cancer awareness, making them more open to vaccination for cancer prevention; 2) Physical activity also associated with greater vaccine acceptance; 3) Users of complementary and alternative therapy are less accepting of vaccine.
Vaccination against seasonal influenza is safe and produces a protective immune response in infants as young as 6 to 12 weeks, concludes a study in the February issue of The Pediatric Infectious Disease Journal.
The Lancet, a premier British medical journal, today retracted a study published in 1998 that drew a link between the measles, mumps and rubella (MMR) vaccine and increased incidence of autism. Alan Percy, M.D., professor of pediatric neurology and medical director of the University of Alabama at Birmingham Civitan International Research Center, said the retracted study’s findings long have been questioned by the scientific community.
Researchers from NIST and the Centers for Disease Control and Prevention have completed the first of a series of tests to determine best practices for properly storing and monitoring the temperature of refrigerated vaccines.
C.S. Mott Children’s Hospital National Poll on Children’s Health finds H1N1 immunization rates are more than twice the national average if health care providers strongly recommend H1N1 vaccine
Metastatic prostate cancer patients who received a vaccine of harmless poxviruses engineered to spur an immune system attack on prostate tumor cells lived substantially longer than patients who received a placebo vaccine, report researchers at Dana-Farber Cancer Institute and affiliated organizations.
For people who haven't had chickenpox and are exposed to an ill family member, getting vaccinated within five days can reduce the risk of developing chickenpox—or at least reduce the severity of disease, reports a study in the January issue of The Pediatric Infectious Disease Journal.
Expert at The University of Texas M. D. Anderson Cancer Center provide insight to parents based on what we've learned about about the HPV vaccine in the past four years.
The NJ Poison Control Center's Hotline is telling callers there is no danger if their children received the H1N1 vaccine that was recalled by Sanofi Pasteur, according to Bruce Ruck, Pharm.D., UMDNJ Director of Drug Information and Professional Education.
Researchers from Thomas Jefferson University are one step closer to developing a vaccine against the AIDS disease.
The Johns Hopkins Bloomberg School of Public Health has established the International Vaccine Access Center (IVAC) to increase access to lifesaving vaccines by overcoming many of the obstacles that often delay vaccine usage and distribution.
Although there is high awareness of the need for seasonal influenza vaccines, a new study of Hispanics in one California county shows low rates of actual vaccination, especially among men.
Vaccination to prevent chickenpox (varicella) appears to have an added benefit for children—a reduced risk of shingles (herpes zoster) according to a study in The Pediatric Infectious Disease Journal.
Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called “neglected” diseases that claim millions of lives in the developing world each year. Those hard-to-treat diseases include malaria, tuberculosis, dengue fever, and other conditions. That’s the topic of the cover story scheduled for the current issue of Chemical & Engineering News, ACS’ weekly newsmagazine.
A new vaccine designed to stimulate an immune response against a cancer-causing human papillomavirus (HPV-16) can eliminate chronic infection by the virus and may cause regression of precancerous genital lesions in women who receive the vaccine.
Pregnant women with significant symptoms of depression tend to have a stronger biological reaction to the seasonal flu vaccine than do women with lower depression levels, according to a new study.
Funding for two research projects at the University of California, San Diego School of Medicine are among the 76 grants announced by the Bill & Melinda Gates Foundation in the third funding round of Grand Challenges Explorations, an initiative to help scientists around the world explore bold and largely unproven ways to improve health in developing countries.
Medical clinics the world over could benefit from new software created at NIST, where a team of scientists has found a way to improve the efficiency of a pneumonia vaccine testing method developed at the University of Alabama at Birmingham.
A new cervical cancer vaccine approved Oct. 16 by the Food and Drug Administration was developed as a result of research at Loyola University Chicago Stritch School of Medicine.
A University of Illinois at Chicago study finds girls and young women do not believe the human papillomavirus vaccine protects them against other sexually transmitted infections, nor do they believe they should stop cervical cancer screening.
An apparent allergic reaction after an immunization should be investigated rather than avoiding future immunizations, which could leave patients at greater risk of disease, according to new medical guidelines.
C.S. Mott Children’s Hospital National Poll on Children’s Health finds nearly 90% of public supports required H1N1 vaccination for health care workers in case of outbreak, while only 38% of health care workers intend to get vaccinated.
Unfortunately, kids will probably be dismayed to learn that they will need an extra shot this year since recommendations call for children to receive both a seasonal flu vaccine and the H1N1 vaccine. Here are some tips to help kids survive the needle sticks.
UNC expert available to discuss latest development in search for AIDS vaccine.
Immune therapies have been explored as a way to treat cancer after it develops. But a new study from the University of Michigan Comprehensive Cancer Center suggests that genetic risk of prostate cancer can be reduced by rescuing critical immune system cells.
A person, usually a child, dies of rabies every 20 minutes. However, only one inoculation may be all it takes for rabies vaccination, according to new research published in the Journal of Infectious Diseases by researchers at the Jefferson Vaccine Center.
University of Michigan scientists have moved closer to the first effective vaccine to prevent urinary tract infections, if the robust immunity achieved in mice can be reproduced in humans. Half of all women and 14 percent of men experience urinary tract infections, some repeatedly.
A new vaccine against pneumonia may offer better protection from chronic obstructive pulmonary disease (COPD) patients than the currently accepted vaccine, according to recent research that will be published in the September 15 issue of the American Journal of the Respiratory and Critical Care Journal, a publication of the American Thoracic Society.
Researchers at Albert Einstein College of Medicine of Yeshiva University have identified two small protein fragments that could be developed into an anthrax vaccine that may cause fewer side effects than the current vaccine.
The Bioproduction Facility at Cornell University has produced the first batch of NY-ESO-1 recombinant protein—a cancer vaccine—that will be used in clinical trials for patients facing either ovarian cancer or melanoma. The facility was developed as a partnership between The Ludwig Institute for Cancer Research and Cornell University.
An analysis of the adverse events reported following distribution of quadrivalent human papillomavirus recombinant vaccine since 2006 indicates that adverse event rates were consistent with pre-licensing data and expected background rates of other vaccines, with the exception of a higher proportion of reports of fainting and blood clots, according to a study in the August 19 issue of JAMA.
1) Approximately 50 percent do not recommend the vaccine; 2) Those who hear scientific information more likely to recommend; 3) Study confined to Texas, but representative of national mood.
Researchers at the Johns Hopkins Malaria Research Institute have for the first time produced a malarial protein (Pfs48/45) in the proper conformation and quantity to generate a significant immune response in mice and non-human primates for use in a potential transmission-blocking vaccine. Antibodies induced by Pfs48/45 protein vaccine effectively blocked the sexual development of the malaria-causing parasite, Plasmodium, as it grows within the mosquito.
There is no evidence that giving infants a combination vaccine for diphtheria, tetanus, pertussis, and hepatitis B along with a form of flu protects them as effectively as separate vaccines.
Infants who received two or three primary doses of the 7-valent pneumococcal conjugate vaccine (PCV-7) both had a decreased rate of carrying pneumococcal microorganisms that can cause pneumonia and other infections, compared to infants who were not vaccinated, according to a study in the July 8 issue of JAMA.
After a vaccination or an infection, the human immune system remembers to keep protecting against invaders it has already encountered, with the aid of specialized B-cells and T-cells. Immunological memory has long been the subject of intense study, but the underlying cellular mechanisms regulating the generation and persistence of long-lived memory T cells remain largely undefined. Now, researchers have found that a common anti-diabetic drug might enhance the effectiveness of vaccines.
A Saint Louis University researcher will present findings on the potential of a vaccine to protect against death and serious illness from influenza at an infectious diseases conference Monday.
Flu vaccine delivered through skin patches containing microneedles has proven just as effective at preventing influenza in mice as intramuscular, hypodermic flu immunization. The microneedle patches could improve seasonal vaccination coverage.
An urgently needed new tuberculosis vaccine cleared a vital step in testing, an important advance at time when a third of the world's population is believed to be have latent tuberculosis infection (LTBI), which, when re-activated, can cause full-blown disease.
Administration of a tissue-cultured smallpox vaccine showed signs of an effective vaccine response with no serious adverse events, according to a study in the March 11 issue of JAMA.
A study among U.S. military personnel finds that those who received a flu shot with the trivalent inactivated vaccine had fewer subsequent health care visits related to pneumonia and influenza than those who received an intranasal live attenuated influenza vaccine, according to a study appearing in the March 4 issue of JAMA, and being released early online with two other reports on drug-resistant influenza.
Protection against Ebola, one of the world's deadliest viruses, can be achieved by a vaccine produced in insect cells, raising prospects for developing an effective vaccine for humans, say scientists at the Southwest Foundation for Biomedical Research (SFBR) in San Antonio.
Scientists have developed a way to manipulate bacteria so they will grow mutant sugar molecules on their cell surfaces that could be used against them as the key component in potent vaccines.
UAB researchers have developed a new, inexpensive and efficient method for producing and studying a type of human papillomavirus (HPV) that causes cervical cancer. The process could speed understanding of how the virus functions and causes diseases, and lead to new prevention or treatment options.